Valeant’s Pursuit of Allergan: Go Big or Go Home

May 21, 2014, 7:18 am

≫ Next: Allergan criticises performance of Valeant's recent acquisitions

≪ Previous: Ackman says Allergan CEO has conflict of interest on takeover offer

$

0

0

Valeant’s Pursuit of Allergan: Go Big or Go Home

Motley Fool

---

Allergan criticises performance of Valeant's recent acquisitions

May 27, 2014, 7:08 am

≫ Next: Allergan investors want up to $200 per share from Valeant

≪ Previous: Valeant’s Pursuit of Allergan: Go Big or Go Home

$

0

0

Allergan criticises performance of Valeant's recent acquisitions

First Word Pharma

Allergan investors want up to $200 per share from Valeant

May 27, 2014, 6:05 pm

≫ Next: Nestle boosts skincare business with $1.4 bln Valeant deal

≪ Previous: Allergan criticises performance of Valeant's recent acquisitions

$

0

0

Allergan investors want up to $200 per share from Valeant

Fierce Pharma

Nestle boosts skincare business with $1.4 bln Valeant deal

May 28, 2014, 6:25 am

≫ Next: Valeant raises proposal for Allergan by $10.00 per share to $58.30 per share

≪ Previous: Allergan investors want up to $200 per share from Valeant

$

0

0

Nestle boosts skincare business with $1.4 bln Valeant deal

Yahoo/Reuters

Valeant raises proposal for Allergan by $10.00 per share to $58.30 per share

May 28, 2014, 6:26 am

≫ Next: Valeant ups the ante for Allergan instead of waiting for rejection

≪ Previous: Nestle boosts skincare business with $1.4 bln Valeant deal

$

0

0

Valeant raises proposal for Allergan by $10.00 per share to $58.30 per share

The Fly on the Wall

Valeant ups the ante for Allergan instead of waiting for rejection

May 30, 2014, 1:42 pm

≫ Next: Valeant, Pershing prepare to go hostile in Allergan bid

≪ Previous: Valeant raises proposal for Allergan by $10.00 per share to $58.30 per share

$

0

0

Valeant ups the ante for Allergan instead of waiting for rejection

Marketwatch

Valeant, Pershing prepare to go hostile in Allergan bid

June 3, 2014, 11:25 am

≫ Next: Is Valeant’s Big Offer for Allergan Big Enough?

≪ Previous: Valeant ups the ante for Allergan instead of waiting for rejection

$

0

0

Valeant, Pershing prepare to go hostile in Allergan bid

Yahoo/Reuters

Is Valeant’s Big Offer for Allergan Big Enough?

June 5, 2014, 9:22 am

≫ Next: FDA approves Valeant's toenail fungus treatment Jublia, drugmaker plans 3rd quarter launch

≪ Previous: Valeant, Pershing prepare to go hostile in Allergan bid

$

0

0

Is Valeant’s Big Offer for Allergan Big Enough?

Motley Fool

---

FDA approves Valeant's toenail fungus treatment Jublia, drugmaker plans 3rd quarter launch

June 9, 2014, 6:15 am

≫ Next: Ackman says Allergan holders back takeover at $180

≪ Previous: Is Valeant’s Big Offer for Allergan Big Enough?

$

0

0

FDA approves Valeant's toenail fungus treatment Jublia, drugmaker plans 3rd quarter launch

Yahoo/AP

Ackman says Allergan holders back takeover at $180

June 9, 2014, 6:23 am

≫ Next: Ackman says followed the rules with Allergan investment

≪ Previous: FDA approves Valeant's toenail fungus treatment Jublia, drugmaker plans 3rd quarter launch

$

0

0

Ackman says Allergan holders back takeover at $180

Reuters

Ackman says followed the rules with Allergan investment

June 9, 2014, 6:42 am

≫ Next: Allergan Board Rejects Valeant’s Latest $54 Billion Bid

≪ Previous: Ackman says Allergan holders back takeover at $180

$

0

0

Ackman says followed the rules with Allergan investment

Reuters

Allergan Board Rejects Valeant’s Latest $54 Billion Bid

June 10, 2014, 7:43 am

≫ Next: Valeant plans hostile bid after Allergan board unanimously rebuffs latest acquisition offer

≪ Previous: Ackman says followed the rules with Allergan investment

$

0

0

Allergan Board Rejects Valeant’s Latest $54 Billion Bid

Bloomberg

Valeant plans hostile bid after Allergan board unanimously rebuffs latest acquisition offer

June 10, 2014, 4:23 pm

≫ Next: The Valeant Strategy: A Sustainable Model or a Shell Game?

≪ Previous: Allergan Board Rejects Valeant’s Latest $54 Billion Bid

$

0

0

Valeant plans hostile bid after Allergan board unanimously rebuffs latest acquisition offer

Yahoo/AP

The Valeant Strategy: A Sustainable Model or a Shell Game?

June 12, 2014, 6:28 am

≫ Next: VALEANT: How A Canadian Pharmaceutical Company Could Destroy The Industry As We Know It

≪ Previous: Valeant plans hostile bid after Allergan board unanimously rebuffs latest acquisition offer

$

0

0

The Valeant Strategy: A Sustainable Model or a Shell Game?

WSJ Online

VALEANT: How A Canadian Pharmaceutical Company Could Destroy The Industry As We Know It

June 12, 2014, 7:09 am

≫ Next: Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong

≪ Previous: The Valeant Strategy: A Sustainable Model or a Shell Game?

$

0

0

VALEANT: How A Canadian Pharmaceutical Company Could Destroy The Industry As We Know It

Yahoo/Business Insider

---

Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong

June 12, 2014, 11:18 am

≫ Next: Allergan-Valeant Deal Gets Pershing Poison Pill Warning

≪ Previous: VALEANT: How A Canadian Pharmaceutical Company Could Destroy The Industry As We Know It

$

0

0

Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong

Forbes

Allergan-Valeant Deal Gets Pershing Poison Pill Warning

June 13, 2014, 6:43 am

≫ Next: Valeant Headlines Puncture Strategy as Stock Drops: Opening Line

≪ Previous: Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong

$

0

0

Allergan-Valeant Deal Gets Pershing Poison Pill Warning

Bloomberg

Valeant Headlines Puncture Strategy as Stock Drops: Opening Line

June 13, 2014, 6:44 am

≫ Next: Allergan Quotes Morgan Stanley to Attack Valeant, a Morgan Stanley Client

≪ Previous: Allergan-Valeant Deal Gets Pershing Poison Pill Warning

$

0

0

Valeant Headlines Puncture Strategy as Stock Drops: Opening Line

Bloomberg

Allergan Quotes Morgan Stanley to Attack Valeant, a Morgan Stanley Client

June 16, 2014, 8:30 am

≫ Next: Valeant Readies Hostile Exchange Offer for Allergan

≪ Previous: Valeant Headlines Puncture Strategy as Stock Drops: Opening Line

$

0

0

Allergan Quotes Morgan Stanley to Attack Valeant, a Morgan Stanley Client

WSJ Online

Valeant Readies Hostile Exchange Offer for Allergan

June 17, 2014, 4:07 pm

≫ Next: Time Isn’t on Valeant’s Side in Allergan Bid

≪ Previous: Allergan Quotes Morgan Stanley to Attack Valeant, a Morgan Stanley Client

$

0

0

Valeant Readies Hostile Exchange Offer for Allergan

TheStreet.com